tiprankstipranks
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
US Market
BTAI
Bioxcel Therapeutics
RESEARCH TOOLSreports
Want to see BTAI full AI Analyst Report?

Bioxcel Therapeutics (BTAI) Income Statement

1,936 Followers

Bioxcel Therapeutics Income Statement

Last quarter (Q1 2026), Bioxcel Therapeutics's total revenue was $206.00K, an increase of 22.62% from the same quarter last year. In Q1, Bioxcel Therapeutics's net income was $-12.69M. See Bioxcel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 642.00K$ 2.27M$ 1.38M$ 375.00K$ 0.00
Gross Profit
$ 478.00K$ 123.00K$ 120.00K$ 355.00K$ 0.00
Operating Expenses
$ 50.74M$ 67.37M$ 171.90M$ 160.00M$ 106.94M
Depreciation and Amortization
$ 300.00K$ 309.00K$ 318.00K$ 327.00K$ 297.00K
EBITDA
$ -52.61M$ -44.16M$ -165.42M$ -157.22M$ -106.59M
Operating Income
$ -50.27M$ -67.25M$ -171.78M$ -159.65M$ -106.94M
Other Income/Expenses
$ -19.63M$ 7.65M$ -7.27M$ -6.11M$ 3.00K
Pretax Income
$ -69.90M$ -59.60M$ -179.05M$ -165.76M$ -106.93M
Net Income
$ -69.90M$ -59.60M$ -179.05M$ -165.76M$ -106.93M
Per Share Metrics
Basic EPS
$ -5.73$ -23.51$ -98.35$ -94.67$ -64.87
Diluted EPS
$ -5.73$ -23.51$ -98.35$ -94.67$ -64.87
Weighted Average Shares Outstanding
 12.21M 2.54M 1.82M 1.75M 1.65M
Weighted Average Shares Outstanding (Diluted)
 12.21M 2.54M 1.82M 1.75M 1.65M
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History